203 related articles for article (PubMed ID: 20830287)
1. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
Goletti D; Raja A; Syed Ahamed Kabeer B; Rodrigues C; Sodha A; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
PLoS One; 2010 Sep; 5(9):e12577. PubMed ID: 20830287
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
[TBL] [Abstract][Full Text] [Related]
3. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
Vanini V; Petruccioli E; Gioia C; Cuzzi G; Orchi N; Rianda A; Alba L; Giancola ML; Conte A; Schininà V; Rizzi EB; Girardi E; Goletti D
J Infect; 2012 Jul; 65(1):49-59. PubMed ID: 22465752
[TBL] [Abstract][Full Text] [Related]
4. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
Kabeer BS; Raja A; Raman B; Thangaraj S; Leportier M; Ippolito G; Girardi E; Lagrange PH; Goletti D
BMC Infect Dis; 2011 May; 11():135. PubMed ID: 21595874
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
7. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
9. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
10. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.
Ruhwald M; Petersen J; Kofoed K; Nakaoka H; Cuevas LE; Lawson L; Squire SB; Eugen-Olsen J; Ravn P
PLoS One; 2008 Aug; 3(8):e2858. PubMed ID: 18682747
[TBL] [Abstract][Full Text] [Related]
11. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects.
Kabeer BS; Sikhamani R; Raja A
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):236-43. PubMed ID: 21996360
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the
Tang Y; Yu Y; Wang Q; Wen Z; Song R; Li Y; Zhou Y; Ma R; Jia H; Bai S; Abdulsalam H; Du B; Sun Q; Xing A; Pan L; Wang J; Song Y
Front Cell Infect Microbiol; 2023; 13():1152665. PubMed ID: 37333845
[TBL] [Abstract][Full Text] [Related]
14. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.
Ruhwald M; Bodmer T; Maier C; Jepsen M; Haaland MB; Eugen-Olsen J; Ravn P;
Eur Respir J; 2008 Dec; 32(6):1607-15. PubMed ID: 18684849
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
17. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
[TBL] [Abstract][Full Text] [Related]
18. A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis.
Holm LL; Rose MV; Kimaro G; Bygbjerg IC; Mfinanga SG; Ravn P; Ruhwald M
Pediatrics; 2014 Dec; 134(6):e1568-75. PubMed ID: 25422019
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
